A National Movement Built on Urgency, Experience, and Science
A National Movement Built on Urgency, Experience, and Science
A working group bill is introduced to explore psychedelic-assisted therapy, marking a critical step toward policy innovation.
VMHLC helps lead efforts behind Texas HB 1802, calling for research into psychedelic therapies for PTSD.
Brett Waters, LtGen Marty Steele, and Lynette Averill establish Reason for Hope to advocate for psychedelic therapy access nationwide.
Governor Lamont signs HB 5396 into law, paving the way for MDMA and psilocybin therapy for veterans and first responders.
A working group bill is introduced to explore psychedelic-assisted therapy, marking a critical step toward policy innovation.
The organizations publicly support bipartisan legislation to reclassify MDMA and psilocybin for research and treatment.
Senators Booker and Paul, and Reps. Mace and Dean, sponsor legislation to accelerate psychedelic treatment access.
State lawmakers fund the pilot program passed in 2022, ensuring clinical implementation through Yale University.
VMHLC helps organize statewide advocacy for using opioid settlement funds to support ibogaine treatment studies.
The coalition organizes legislative visits to Washington, D.C. and Pennsylvania in support of federal psychedelic reform.
Veterans and advocates testify in support of the proposed ibogaine research investment.
Adam Marr presents on the growing role of psychedelic-assisted therapy in veteran mental health.
VMHLC’s co-founder calls on lawmakers to pass the Breakthrough Therapies Act to save veteran lives.
Connecticut’s pilot program prepares for participant enrollment following final institutional review.
New officials express concern over safety and efficacy, stalling the previously supported funding proposal.
The state backs away from the landmark psychedelic initiative amid political shifts and risk concerns.
Attorney General Russell Coleman suggests revisiting the allocation to support innovative addiction treatment.
Veterans and others begin accessing legal, state-funded psilocybin therapy under Yale’s guidance.
With contributions from Adam Marr and Dr. Lynnette Averill, Beond’s new program provides supervised ibogaine treatment to veterans and first responders.
State-supported psilocybin therapy becomes accessible to eligible veterans and residents with mental health challenges.
Adam Marr shares his personal story and VMHLC’s mission at a national veteran wellness committee meeting.
VMHLC advocacy assists in the largest publicly funded psychedelic research investment in U.S. history.
VMHLC, RFH, and Coalition Members lead effort to create a Psychedelic-Assisted Therapy Task Force in NC.
Lt. General Steele and Adam Marr speak at the Mental Health Prague 2025 conference where they discussed Veteran’s mental health and emerging therapies.
Dr. Lynette Averill, Jesse MacLachlan, and Adam Marr of RFH and the VMHLC grace the stages of Psych Science 2025 to share their thought leadership on multiple panels.
Whether you’re a Veteran, clinician, policymaker, or ally—there’s a role for you here.
Connect with fellow advocates and drive change.
Fuel the mission. Fund access, advocacy, and hope.
Volunteer, attend events, or share your story.
Veteran die by suicide and drug
overdoses every day.
Veteran are 1.5x more likely to die
by overdose than civilians.
Over 200,000 Veteran have died from suicide and overdose
since 9/11.
leave the country they served for overseas psychedelic therapy because the system won’t support them.
“This isn’t just a crisis. It’s a moral failing. And we’re done waiting.”
VMHLC is powered by a national coalition of Veteran-led organizations, clinicians, researchers, advocates, and families—united in one mission: to end the suicide crisis and revolutionize mental health care.
“We are Veterans still in service—fighting for the right to heal.”
Donate Now